IGF1R and non-small cell lung carcinoma: This technique not only takes one and a half hours, but was also successful in identifying the insulin-like growth factor 1R (IGF-1R) – a potential biomarker for non-small cell lung cancer (NSCLC), in plasma of patients with NSCLC.